Angiogenesis is a hallmark of HCC progression, with vascular endothelial growth factor (VEGF) and its receptor (VEGFR) playing pivotal roles in regulating both tumor angiogenesis and immunosuppression. The gene discussed is KDR; the disease is hepatocellular carcinoma.